1.
Schwarz CW, Näslund-Koch C, Zachariae C, Seidelin JB, Nielsen SD, Ostrowski SR, et al. Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors. Acta Derm Venereol [Internet]. 2025 Aug. 18 [cited 2026 May 25];105:adv43685. Available from: https://medicaljournalssweden.se/actadv/article/view/43685